ICON Named Business & Finance Company of the Year and One of Forbes’ Best Employers for Diversity
ICON kick starts the first half of 2022 with a string of prestigious industry awards recognising healthcare intelligence work and staff, as independently judged by peers worldwide
DUBLIN, May 23, 2022–(BUSINESS WIRE)–ICON plc, (NASDAQ: ICLR) a global provider of drug and device development and commercialisation